Suppr超能文献

年龄和淀粉样蛋白沉积对人类中枢神经系统中Aβ动力学的影响。

Effects of age and amyloid deposition on Aβ dynamics in the human central nervous system.

作者信息

Huang Yafei, Potter Rachel, Sigurdson Wendy, Santacruz Anna, Shih Shirley, Ju Yo-El, Kasten Tom, Morris John C, Mintun Mark, Duntley Stephen, Bateman Randall J

机构信息

Department of Neurology, Washington University School of Medicine, 660 S Euclid, PO Box 8111, St Louis, MO 63110, USA.

出版信息

Arch Neurol. 2012 Jan;69(1):51-8. doi: 10.1001/archneurol.2011.235. Epub 2011 Sep 12.

Abstract

BACKGROUND

The amyloid hypothesis predicts that increased production or decreased clearance of β-amyloid (Aβ) leads to amyloidosis, which ultimately culminates in Alzheimer disease (AD).

OBJECTIVE

To investigate whether dynamic changes in Aβ levels in the human central nervous system may be altered by aging or by the pathology of AD and thus contribute to the risk of AD.

DESIGN

Repeated-measures case-control study.

SETTING

Washington University School of Medicine in St Louis, Missouri.

PARTICIPANTS

Participants with amyloid deposition, participants without amyloid deposition, and younger normal control participants.

MAIN OUTCOME MEASURES

In this study, hourly cerebrospinal fluid (CSF) Aβ concentrations were compared with age, status of amyloid deposition, electroencephalography, and video recording data.

RESULTS

Linear increases were observed over time in the Aβ levels in CSF samples obtained from the younger normal control participants and the older participants without amyloid deposition, but not from the older participants with amyloid deposition. Significant circadian patterns were observed in the Aβ levels in CSF samples obtained from the younger control participants; however, circadian amplitudes decreased in both older participants without amyloid deposition and older participants with amyloid deposition. Aβ diurnal concentrations were correlated with the amount of sleep but not with the various activities that the participants participated in while awake.

CONCLUSIONS

A reduction in the linear increase in the Aβ levels in CSF samples that is associated with amyloid deposition and a decreased CSF Aβ diurnal pattern associated with increasing age disrupt the normal physiology of Aβ dynamics and may contribute to AD.

摘要

背景

淀粉样蛋白假说预测,β-淀粉样蛋白(Aβ)生成增加或清除减少会导致淀粉样变性,最终引发阿尔茨海默病(AD)。

目的

研究人类中枢神经系统中Aβ水平的动态变化是否会因衰老或AD病理改变而发生改变,进而导致AD发病风险增加。

设计

重复测量病例对照研究。

地点

密苏里州圣路易斯市华盛顿大学医学院。

参与者

有淀粉样蛋白沉积的参与者、无淀粉样蛋白沉积的参与者以及年轻正常对照参与者。

主要观察指标

在本研究中,将每小时脑脊液(CSF)Aβ浓度与年龄、淀粉样蛋白沉积状态、脑电图及视频记录数据进行比较。

结果

在年轻正常对照参与者和无淀粉样蛋白沉积的老年参与者的脑脊液样本中,Aβ水平随时间呈线性增加,但有淀粉样蛋白沉积的老年参与者未出现这种情况。在年轻对照参与者的脑脊液样本中观察到显著的昼夜节律模式;然而,无淀粉样蛋白沉积的老年参与者和有淀粉样蛋白沉积的老年参与者的昼夜节律振幅均降低。Aβ的日间浓度与睡眠时间相关,但与参与者清醒时参与的各种活动无关。

结论

与淀粉样蛋白沉积相关的脑脊液样本中Aβ水平线性增加的减少以及与年龄增长相关的脑脊液Aβ昼夜模式的改变破坏了Aβ动态变化的正常生理过程,可能导致AD。

相似文献

1
Effects of age and amyloid deposition on Aβ dynamics in the human central nervous system.
Arch Neurol. 2012 Jan;69(1):51-8. doi: 10.1001/archneurol.2011.235. Epub 2011 Sep 12.
2
Associations Between β-Amyloid Kinetics and the β-Amyloid Diurnal Pattern in the Central Nervous System.
JAMA Neurol. 2017 Feb 1;74(2):207-215. doi: 10.1001/jamaneurol.2016.4202.
3
β-amyloid dynamics in human plasma.
Arch Neurol. 2012 Dec;69(12):1591-7. doi: 10.1001/archneurol.2012.18107.
4
APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.
Ann Neurol. 2010 Jan;67(1):122-31. doi: 10.1002/ana.21843.
6
Diurnal patterns of soluble amyloid precursor protein metabolites in the human central nervous system.
PLoS One. 2014 Mar 19;9(3):e89998. doi: 10.1371/journal.pone.0089998. eCollection 2014.
8
Circadian Rest-Activity Pattern Changes in Aging and Preclinical Alzheimer Disease.
JAMA Neurol. 2018 May 1;75(5):582-590. doi: 10.1001/jamaneurol.2017.4719.

引用本文的文献

1
Circadian rhythms are associated with higher amyloid-β and tau and poorer cognition in older adults.
Brain Commun. 2025 Sep 8;7(5):fcaf322. doi: 10.1093/braincomms/fcaf322. eCollection 2025.
2
SLEEP AND NEURODEGENERATION: EXAMINING POTENTIAL PHYSIOLOGICAL MECHANISMS.
Curr Sleep Med Rep. 2025 Dec;11(1). doi: 10.1007/s40675-024-00316-6. Epub 2025 Jan 3.
5
Soluble VCAM-1 May Serve as a Pharmacodynamic CSF Marker to Monitor BACE2 Activity in Non-Human Primates.
Mol Cell Proteomics. 2025 Jun 4;24(7):101012. doi: 10.1016/j.mcpro.2025.101012.
6
Associations of Cerebrospinal Fluid Orexin-A, Alzheimer Disease Biomarkers, and Cognitive Performance.
Ann Clin Transl Neurol. 2025 Apr;12(4):780-791. doi: 10.1002/acn3.70009. Epub 2025 Feb 17.
7
Sleep Patterns and Human Brain Health.
Neuroscientist. 2025 Oct;31(5):483-498. doi: 10.1177/10738584241309850. Epub 2025 Jan 30.
8
Accelerometer-measured physical activity timing with incident dementia.
Alzheimers Dement. 2025 Feb;21(2):e14452. doi: 10.1002/alz.14452. Epub 2025 Jan 27.
9
Association of rapid eye movement sleep latency with multimodal biomarkers of Alzheimer's disease.
Alzheimers Dement. 2025 Feb;21(2):e14495. doi: 10.1002/alz.14495. Epub 2025 Jan 27.
10
Disruption in Sleep and Circadian Rhythm: A Potential Accelerator in Alzheimer's Disease Progression.
Ann Neurosci. 2024 Oct;31(4):246-249. doi: 10.1177/09727531231200958. Epub 2023 Nov 9.

本文引用的文献

1
Decreased clearance of CNS beta-amyloid in Alzheimer's disease.
Science. 2010 Dec 24;330(6012):1774. doi: 10.1126/science.1197623. Epub 2010 Dec 9.
2
Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle.
Science. 2009 Nov 13;326(5955):1005-7. doi: 10.1126/science.1180962. Epub 2009 Sep 24.
4
Widespread changes in synaptic markers as a function of sleep and wakefulness in Drosophila.
Science. 2009 Apr 3;324(5923):109-12. doi: 10.1126/science.1166673.
5
Amyloid-beta dynamics correlate with neurological status in the injured human brain.
Science. 2008 Aug 29;321(5893):1221-4. doi: 10.1126/science.1161591.
6
Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo.
Neuron. 2008 Apr 10;58(1):42-51. doi: 10.1016/j.neuron.2008.02.003.
7
Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity.
Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10673-8. doi: 10.1073/pnas.0700148104. Epub 2007 Jun 5.
8
Longitudinal stability of CSF biomarkers in Alzheimer's disease.
Neurosci Lett. 2007 May 23;419(1):18-22. doi: 10.1016/j.neulet.2007.03.064. Epub 2007 Apr 6.
9
Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker.
Neurology. 2007 Feb 27;68(9):666-9. doi: 10.1212/01.wnl.0000256043.50901.e3.
10
Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.
Arch Neurol. 2007 Mar;64(3):343-9. doi: 10.1001/archneur.64.3.noc60123. Epub 2007 Jan 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验